HIGH POWER SHORT DURATION VS LOW POWER LONG DURATION CATHETER ABLATION OF ATRIAL FIBRILLATION
DOI:
https://doi.org/10.61841/4a4az509Keywords:
Atrial fibrillation, ablation, high power short duration, low power long durationAbstract
Backgrounds: Atrial Fibrillation (AF) is a known common arrythmia, affecting around 33 million people worldwide. Catheter ablation is a safe and effective treatment for paroxysmal and persistent AF that are unresponsive to drug treatment. However, long procedural duration of AF ablation has raised the concern of radiation hazard and post-procedural complications. The high power short duration (HPSD) technique is an emerging method that has been introduced as an alternative to reduce procedural time of AF ablation.
Objective: This study attempts to review the safety and efficacy of HSPD compared to the conventional low power long duration (LPLD) ablation in AF patients.
Method: A search through PubMed, Science Direct, JSTORE, and clinicaltrial.gov was conducted. The keywords used were (catheter ablation OR radiofrequency OR pulmonary vein isolation) AND (atrial fibrillation) AND (high power short duration OR 50 W). The search was limited from 2006 to 2024. Risk of bias assessment was conducted through NewcastleOttawa Scale (NOS) assessment.
Results: Among 55,802 journals reviewed, we retrieved 10 journals that met the inclusion criteria. This study found that HPSD ablation results in either better or comparable efficacy in maintaining long term sinus rhythm post ablation. Additionally, there was no difference in safety for both HPSD and LPLD. We also recommend using esophageal temperature monitoring probe and adjusting energy delivery during posterior wall ablation to avoid injuring esophagus.
Conclusion: Our study concluded that HPSD ablation is a safe choice of treatment for drug-refractory paroxysmal or persistent AF with a noteworthy outcome compared to LPLD ablation.
References
McCarthy PM, Cox JL, Kislitsina ON, Kruse J, Churyla A, Malaisrie SC, et al. Surgery and Catheter Ablation for Atrial Fibrillation: History, Current Practice, and Future Directions. J Clin Med. 2021 Dec 31;11(1):210.
Parameswaran R, Al-Kaisey AM, Kalman JM. Catheter ablation for atrial fibrillation: current indications and evolving technologies. Nat Rev Cardiol. 2021 Mar 13;18(3):210–25.
Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, et al. 2017
HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017 Oct;14(10):e275–444.
Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins. New England Journal of Medicine. 1998 Sep 3;339(10):659–66.
La Rosa G, Quintanilla JG, Salgado R, González‐Ferrer JJ, Cañadas‐Godoy V, Pérez‐Villacastín J, et al. Anatomical targets and expected outcomes of catheter‐based ablation of atrial fibrillation in 2020. Pacing and Clinical Electrophysiology. 2021 Feb 31;44(2):341–59.
Kotadia ID, Williams SE, O’Neill M. High-power, Short-duration Radiofrequency Ablation for the Treatment of AF. Arrhythm Electrophysiol Rev. 2020 Feb 11;8(4):265–72.
Gupta A, Perera T, Ganesan A, Sullivan T, Lau DH, Roberts-Thomson KC, et al. Complications of Catheter Ablation of Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2013 Dec;6(6):1082–8.
Yamagata K, Aldhoon B, Kautzner J. Reduction of Fluoroscopy Time and Radiation Dosage During Catheter Ablation for Atrial Fibrillation. Arrhythm Electrophysiol Rev. 2016;5(2):144.
Bhaskaran A, Chik W, Pouliopoulos J, Nalliah C, Qian P, Barry T, et al. Five seconds of 50–60 W radio frequency atrial ablations were transmural and safe: an in vitro mechanistic assessment and force-controlled in vivo validation. Europace. 2016 May 20;euw077.
Chieng D, Segan L, Sugumar H, Al-Kaisey A, Hawson J, Moore BM, et al. Higher power short duration vs. lower power longer duration posterior wall ablation for atrial fibrillation and oesophageal injury outcomes: a prospective multi-centre randomized controlled study (Hi-Lo HEAT trial). EP Europace. 2023 Feb 16;25(2):417–24.
Winkle RA, Mohanty S, Patrawala RA, Mead RH, Kong MH, Engel G, et al. Low complication rates using high power (45–50 W) for short duration for atrial fibrillation ablations. Heart Rhythm. 2019 Feb 1;16(2):165–9.
Joza J, Nair GM, Birnie DH, Nery PB, Redpath CJ, Sarrazin J, et al. High‐power short‐duration versus low‐power long‐duration ablation for pulmonary vein isolation: A substudy of the AWARE randomized controlled trial. J Cardiovasc Electrophysiol. 2024 Jan 21;35(1):136–45.
Kaneshiro T, Takeishi Y. Esophageal thermal injury in catheter ablation of atrial fibrillation. Fukushima J Med Sci. 2021;67(3):2021–3.
Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.
Chen WJ, Gan CX, Cai YW, Liu YY, Xiao PL, Zou LL, et al. Impact of high-power short-duration atrial fibrillation ablation technique on the incidence of silent cerebral embolism: a prospective randomized controlled study. BMC Med. 2023 Dec 1;21(1).
Chen CC, Lee PT, Van Ba V, Chuang CM, Lin YJ, Lo LW, et al. Comparison of lesion characteristics between conventional and high-power short-duration ablation using contact force-sensing catheter in patients with paroxysmal atrial fibrillation. BMC Cardiovasc Disord. 2021 Dec 1;21(1).
Chieng D, Segan L, Sugumar H, Al-Kaisey A, Hawson J, Moore BM, et al. Higher power short duration vs. lower power longer duration posterior wall ablation for atrial fibrillation and oesophageal injury outcomes: a prospective multi-centre randomized controlled study (Hi-Lo HEAT trial). EP Europace. 2023 Feb 16;25(2):417–24.
Park JW, Yang SY, Kim M, Yu HT, Kim TH, Uhm JS, et al. Efficacy and Safety of High-Power Short-Duration Radiofrequency Catheter Ablation of Atrial Fibrillation. Front Cardiovasc Med. 2021;8.
Sarmento Vassallo F. Better Outcomes in High-Power Short-Duration Compared to Low-Power Long-Duration Atrial Fibrillation Ablation in One-Year Follow-Up. Open Access Journal of Biomedical Science. 2020 Sep 22;2(6).
Nilsson B, Chen X, Pehrson S, Svendsen JH. The effectiveness of a high output/short duration radiofrequency current application technique in segmental pulmonary vein isolation for atrial fibrillation. Europace. 2006 Nov;8(11):962–5.
Mitrzak K, Peller M, Krzowski B, Maciejewski C, Balsam P, Marchel M, et al. Safety and effectiveness of veryhigh-power, short-duration ablation in patients with atrial fibrillation: Preliminary results. Cardiol J. 2022 Dec 29;
Chen C feng, Wu J, Jin C lun, Liu M jun, Xu Y zhou. Comparison of high-power short-duration and low-power long-duration radiofrequency ablation for treating atrial fibrillation: Systematic review and meta-analysis. Clin Cardiol. 2020 Dec 1;43(12):1631–40.
Jin S, Lin W, Fang X, Liao H, Zhan X, Fu L, et al. High-Power, Short-Duration Ablation under the Guidance of Relatively Low Ablation Index Values for Paroxysmal Atrial Fibrillation: Long-Term Outcomes and Characteristics of Recurrent Atrial Arrhythmias. J Clin Med. 2023 Feb 1;12(3).
Okamatsu H, Koyama J, Sakai Y, Negishi K, Hayashi K, Tsurugi T, et al. High‐power application is associated with shorter procedure time and higher rate of first‐pass pulmonary vein isolation in ablation index‐guided atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2019 Dec 21;30(12):2751–8.
Ninomiya Y, Inoue K, Tanaka N, Okada M, Tanaka K, Onishi T, et al. Absence of first‐pass isolation is associated with poor pulmonary vein isolation durability and atrial fibrillation ablation outcomes. J Arrhythm. 2021 Dec 6;37(6):1468–76.
Kottmaier M, Popa M, Bourier F, Reents T, Cifuentes J, Semmler V, et al. Safety and outcome of very high-power short-duration ablation using 70 W for pulmonary vein isolation in patients with paroxysmal atrial fibrillation. EP Europace. 2020 Mar 1;22(3):388–93.
Bortone AA, Ramirez FD, Combes S, Laborie G, Albenque JP, Sebag FA, et al. Optimized workflow for pulmonary vein isolation using 90-W radiofrequency applications: a comparative study. Journal of Interventional Cardiac Electrophysiology. 2023 Aug 28;
Romero J, Avendano R, Grushko M, Diaz JC, Du X, Gianni C, et al. Oesophageal Injury During AF Ablation: Techniques for Prevention. Arrhythm Electrophysiol Rev. 2018;7(1):24.
Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, et al.
HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary. EP Europace. 2018 Jan 1;20(1):157–208.
Abdulsalam NM, Sridhar AM, Tregoning DM, He BJ, Jafarvand M, Mehri A, et al. Esophageal luminal temperature monitoring using a multi-sensor probe lowers the risk of esophageal injury in cryo and radiofrequency catheter ablation for atrial fibrillation. Journal of Interventional Cardiac Electrophysiology. 2023 Feb 6;66(8):1827–35.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
